Classifying covalent protein binders by their targeted binding site

[Display omitted] Covalent protein targeting represents a powerful tool for protein characterization, identification, and activity modulation. The safety of covalent therapeutics was questioned for many years due to the possibility of off-target binding and subsequent potential toxicity. Researchers...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2024-12, Vol.117, p.130067, Article 130067
Hauptverfasser: Bedewy, Walaa A., Mulawka, John W., Adler, Marc J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page 130067
container_title Bioorganic & medicinal chemistry letters
container_volume 117
creator Bedewy, Walaa A.
Mulawka, John W.
Adler, Marc J.
description [Display omitted] Covalent protein targeting represents a powerful tool for protein characterization, identification, and activity modulation. The safety of covalent therapeutics was questioned for many years due to the possibility of off-target binding and subsequent potential toxicity. Researchers have recently, however, demonstrated many covalent binders as safe, potent, and long-acting therapeutics. Moreover, they have achieved selective targeting among proteins with high structural similarities, overcome mutation-induced resistance, and obtained higher potency compared to non-covalent binders. In this review, we highlight the different classes of binding sites on a target protein that could be addressed by a covalent binder. Upon folding, proteins generate various concavities available for covalent modifications. Selective targeting to a specific site is driven by differences in the geometry and physicochemical properties of the binding pocket residues as well as the geometry and reactivity of the covalent modifier “warhead”. According to the warhead reactivity and the nature of the binding region, covalent binders can alter or lock a targeted protein conformation and inhibit or enhance its activity. We survey these various modification sites using case studies of recently discovered covalent binders, bringing to the fore the versatile application of covalent protein binders with respect to drug discovery approaches.
doi_str_mv 10.1016/j.bmcl.2024.130067
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_3146663697</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X24004694</els_id><sourcerecordid>3146663697</sourcerecordid><originalsourceid>FETCH-LOGICAL-e1097-9c0655b71c927b0edc853468314d9c14889828c4483128381dc8d6d48fce7ad43</originalsourceid><addsrcrecordid>eNo1kE1LxDAQhoMo7rr6BzxIj15aJ02aJuBFil-w4EXBW2iT2TVLP9Yku7D_3tbV08DMMy8zDyHXFDIKVNxtsqYzbZZDzjPKAER5QuaUC54yDsUpmYMSkErFP2fkIoQNAOXA-TmZMSVEWUA5J1XV1iG41cH168QM-7rFPiZbP0R0fdK43qIPSXNI4hc6n8TarzGi_Z1MK8FFvCRnq7oNePVXF-Tj6fG9ekmXb8-v1cMyRQqqTJUBURRNSY3KywbQGlkwLiSj3CpDuZRK5tJwPnZyySQdASsslyuDZW05W5DbY-543vcOQ9SdCwbbtu5x2AU9BgkhmFDliN78obumQ6u33nW1P-j_x0fg_gjgePDeodfBOOwNWufRRG0HpynoybPe6Mmznjzro2f2A-fxbss</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3146663697</pqid></control><display><type>article</type><title>Classifying covalent protein binders by their targeted binding site</title><source>ScienceDirect Journals (5 years ago - present)</source><creator>Bedewy, Walaa A. ; Mulawka, John W. ; Adler, Marc J.</creator><creatorcontrib>Bedewy, Walaa A. ; Mulawka, John W. ; Adler, Marc J.</creatorcontrib><description>[Display omitted] Covalent protein targeting represents a powerful tool for protein characterization, identification, and activity modulation. The safety of covalent therapeutics was questioned for many years due to the possibility of off-target binding and subsequent potential toxicity. Researchers have recently, however, demonstrated many covalent binders as safe, potent, and long-acting therapeutics. Moreover, they have achieved selective targeting among proteins with high structural similarities, overcome mutation-induced resistance, and obtained higher potency compared to non-covalent binders. In this review, we highlight the different classes of binding sites on a target protein that could be addressed by a covalent binder. Upon folding, proteins generate various concavities available for covalent modifications. Selective targeting to a specific site is driven by differences in the geometry and physicochemical properties of the binding pocket residues as well as the geometry and reactivity of the covalent modifier “warhead”. According to the warhead reactivity and the nature of the binding region, covalent binders can alter or lock a targeted protein conformation and inhibit or enhance its activity. We survey these various modification sites using case studies of recently discovered covalent binders, bringing to the fore the versatile application of covalent protein binders with respect to drug discovery approaches.</description><identifier>ISSN: 0960-894X</identifier><identifier>ISSN: 1464-3405</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/j.bmcl.2024.130067</identifier><identifier>PMID: 39667507</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Covalent drugs ; Protein binders</subject><ispartof>Bioorganic &amp; medicinal chemistry letters, 2024-12, Vol.117, p.130067, Article 130067</ispartof><rights>2024 The Author(s)</rights><rights>Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0002-1049-509X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.bmcl.2024.130067$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39667507$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bedewy, Walaa A.</creatorcontrib><creatorcontrib>Mulawka, John W.</creatorcontrib><creatorcontrib>Adler, Marc J.</creatorcontrib><title>Classifying covalent protein binders by their targeted binding site</title><title>Bioorganic &amp; medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>[Display omitted] Covalent protein targeting represents a powerful tool for protein characterization, identification, and activity modulation. The safety of covalent therapeutics was questioned for many years due to the possibility of off-target binding and subsequent potential toxicity. Researchers have recently, however, demonstrated many covalent binders as safe, potent, and long-acting therapeutics. Moreover, they have achieved selective targeting among proteins with high structural similarities, overcome mutation-induced resistance, and obtained higher potency compared to non-covalent binders. In this review, we highlight the different classes of binding sites on a target protein that could be addressed by a covalent binder. Upon folding, proteins generate various concavities available for covalent modifications. Selective targeting to a specific site is driven by differences in the geometry and physicochemical properties of the binding pocket residues as well as the geometry and reactivity of the covalent modifier “warhead”. According to the warhead reactivity and the nature of the binding region, covalent binders can alter or lock a targeted protein conformation and inhibit or enhance its activity. We survey these various modification sites using case studies of recently discovered covalent binders, bringing to the fore the versatile application of covalent protein binders with respect to drug discovery approaches.</description><subject>Covalent drugs</subject><subject>Protein binders</subject><issn>0960-894X</issn><issn>1464-3405</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNo1kE1LxDAQhoMo7rr6BzxIj15aJ02aJuBFil-w4EXBW2iT2TVLP9Yku7D_3tbV08DMMy8zDyHXFDIKVNxtsqYzbZZDzjPKAER5QuaUC54yDsUpmYMSkErFP2fkIoQNAOXA-TmZMSVEWUA5J1XV1iG41cH168QM-7rFPiZbP0R0fdK43qIPSXNI4hc6n8TarzGi_Z1MK8FFvCRnq7oNePVXF-Tj6fG9ekmXb8-v1cMyRQqqTJUBURRNSY3KywbQGlkwLiSj3CpDuZRK5tJwPnZyySQdASsslyuDZW05W5DbY-543vcOQ9SdCwbbtu5x2AU9BgkhmFDliN78obumQ6u33nW1P-j_x0fg_gjgePDeodfBOOwNWufRRG0HpynoybPe6Mmznjzro2f2A-fxbss</recordid><startdate>20241210</startdate><enddate>20241210</enddate><creator>Bedewy, Walaa A.</creator><creator>Mulawka, John W.</creator><creator>Adler, Marc J.</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-1049-509X</orcidid></search><sort><creationdate>20241210</creationdate><title>Classifying covalent protein binders by their targeted binding site</title><author>Bedewy, Walaa A. ; Mulawka, John W. ; Adler, Marc J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-e1097-9c0655b71c927b0edc853468314d9c14889828c4483128381dc8d6d48fce7ad43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Covalent drugs</topic><topic>Protein binders</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bedewy, Walaa A.</creatorcontrib><creatorcontrib>Mulawka, John W.</creatorcontrib><creatorcontrib>Adler, Marc J.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bedewy, Walaa A.</au><au>Mulawka, John W.</au><au>Adler, Marc J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Classifying covalent protein binders by their targeted binding site</atitle><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2024-12-10</date><risdate>2024</risdate><volume>117</volume><spage>130067</spage><pages>130067-</pages><artnum>130067</artnum><issn>0960-894X</issn><issn>1464-3405</issn><eissn>1464-3405</eissn><abstract>[Display omitted] Covalent protein targeting represents a powerful tool for protein characterization, identification, and activity modulation. The safety of covalent therapeutics was questioned for many years due to the possibility of off-target binding and subsequent potential toxicity. Researchers have recently, however, demonstrated many covalent binders as safe, potent, and long-acting therapeutics. Moreover, they have achieved selective targeting among proteins with high structural similarities, overcome mutation-induced resistance, and obtained higher potency compared to non-covalent binders. In this review, we highlight the different classes of binding sites on a target protein that could be addressed by a covalent binder. Upon folding, proteins generate various concavities available for covalent modifications. Selective targeting to a specific site is driven by differences in the geometry and physicochemical properties of the binding pocket residues as well as the geometry and reactivity of the covalent modifier “warhead”. According to the warhead reactivity and the nature of the binding region, covalent binders can alter or lock a targeted protein conformation and inhibit or enhance its activity. We survey these various modification sites using case studies of recently discovered covalent binders, bringing to the fore the versatile application of covalent protein binders with respect to drug discovery approaches.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>39667507</pmid><doi>10.1016/j.bmcl.2024.130067</doi><orcidid>https://orcid.org/0000-0002-1049-509X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0960-894X
ispartof Bioorganic & medicinal chemistry letters, 2024-12, Vol.117, p.130067, Article 130067
issn 0960-894X
1464-3405
1464-3405
language eng
recordid cdi_proquest_miscellaneous_3146663697
source ScienceDirect Journals (5 years ago - present)
subjects Covalent drugs
Protein binders
title Classifying covalent protein binders by their targeted binding site
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T02%3A57%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Classifying%20covalent%20protein%20binders%20by%20their%20targeted%20binding%20site&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Bedewy,%20Walaa%20A.&rft.date=2024-12-10&rft.volume=117&rft.spage=130067&rft.pages=130067-&rft.artnum=130067&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2024.130067&rft_dat=%3Cproquest_pubme%3E3146663697%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3146663697&rft_id=info:pmid/39667507&rft_els_id=S0960894X24004694&rfr_iscdi=true